Connect with us

Technology

EndoDNA Launches BIOS, Turning Genetic Data Into Living Clinical Intelligence for Precision Medicine

Published

on

New platform replaces static, one-time DNA reports with an adaptive dashboard that unifies genomics, biomarkers, and lifestyle data, helping licensed practitioners move from interpretation to action.

STUDIO CITY, Calif., June 16, 2026 /PRNewswire/ — EndoDNA, a precision health intelligence company, today launched BIOS, a patented, intelligent clinical decision-support platform for licensed healthcare practitioners. BIOS replaces the company’s legacy interpretation engine, myDNALive, giving functional, integrative, regenerative, hormone-optimization, and longevity practitioners a continuous, longitudinal view of each patient’s biology.

BIOS, short for Biomedical Reasoning and Adaptive Inference Network, moves precision medicine past static, one-time genetic reports. In their place, it provides an adaptive dashboard that brings together genomics, biomarkers, lifestyle inputs, symptoms, and ongoing patient data.

“For years, clinicians have had access to more biological data than ever before, but very few tools to help them actually apply it,” said Len May, Founder and CEO of EndoDNA. “Most genetic platforms stop at information. BIOS was built to answer the question clinicians are really asking: ‘Now what?’ It transforms complex biology into structured clinical insight that evolves alongside the patient; helping providers move from interpretation to action with greater clarity and consistency.”

Beyond isolated SNPs: built around biological pathways

Unlike consumer DNA platforms or general-purpose AI tools, BIOS is built around interconnected biological pathways rather than isolated single-nucleotide polymorphism (SNP) interpretation. It maps genomic data across vital systems, including:

Hormone metabolism and metabolic signalingInflammation and stress responseNeurotransmitter regulation and cognitive function

In all, BIOS analyzes approximately 1 million validated variants across 21 pathway systems, with 214 pathways actively curated for real-time clinical decision support.

How BIOS works: four connected memory networks

BIOS doesn’t read a single data point in isolation. It reasons across four connected memory networks that build a fuller picture of each patient over time:

World: integrates population-level genomic evidence from sources like biobanks, CPIC, and PharmGKB.Experience: draws on aggregated practitioner case history to surface what has worked for similar patients.Opinion: captures a practitioner’s own notes and overrides to refine and personalize recommendations.Observation: tracks patient-reported outcomes and biomarker trends over time.

Through a single, HIPAA-compliant dashboard, licensed practitioners can order DNA tests, generate unlimited specialized reports from existing genotype files, integrate biomarker and lab data, analyze pharmacogenomic interactions, and query patient genomic data using natural-language search.

Available report categories include Female and Male Regenerative Health, NeuroDNA Cognitive & Neurological Health, Nutrigenomics & Metabolic Pathway Analysis, Endocannabinoid System (ECS) Panels, and Hormone Optimization & Longevity Pathways.

“For years, clinicians have had access to more data than they could reasonably interpret. What has been missing is a reliable way to translate that information into clinical action” says Dr. Allen Lawrence, MA, MD, PhD. “EndoDNA and BIOS help solve that problem by transforming complex genomic and biological inputs into organized, actionable intelligence. The result is a more scalable precision medicine model; one that allows providers to make better-informed decisions, improve patient engagement, and deliver truly personalized care more efficiently.”

A track record of accuracy and patented innovation

Since its founding, EndoDNA has served more than 10,000 patients across 9+ countries through CAP/CLIA-accredited laboratory partners. Using Illumina next-generation sequencing, the company delivers a 99.6% genotyping accuracy rate. EndoDNA holds more than 10 issued and pending patents, including the industry’s only patented methodology for genotyping the endocannabinoid system (ECS), and a patented machine-learning methodology for predicting efficacy from genetic and biometric data.

BIOS is available immediately to licensed healthcare practitioners as a clinical decision-support and research-use platform.

About EndoDNA

EndoDNA is a precision health intelligence company combining genomic sequencing, patented intelligent clinical decision support, and longitudinal biological reasoning for licensed healthcare practitioners. Powered by BIOS, the platform helps clinicians translate genetic and biological data into structured clinical insight across hormone optimization, regenerative medicine, cognitive health, metabolic function, nutrigenomics, and longevity care; supporting pathway-level precision while preserving practitioner-led judgment. Learn more at www.EndoDNA.com.

View original content:https://www.prnewswire.com/news-releases/endodna-launches-bios-turning-genetic-data-into-living-clinical-intelligence-for-precision-medicine-302801069.html

SOURCE EndoDNA

Continue Reading
Click to comment

Leave a Reply

Your email address will not be published. Required fields are marked *

Technology

hand2mind Launches New and Exclusive Back-to-School Products at Target

Published

on

By

Teacher-author collaborations with Tara West and Brooke Brown support hands-on math, literacy, and STEM learning

VERNON HILLS, Ill., June 16, 2026 /PRNewswire/ — hand2mind, a leading provider of hands-on learning tools for classrooms and homes, is launching a lineup of new and exclusive back-to-school products at Target, including classroom-ready tools created with its teacher-author partners Tara West and Brooke Brown.  

The product lineup gives educators and parents easy access to engaging, hands-on learning tools designed to support math, literacy, STEM, and social-emotional learning. Select products will be available exclusively at Target, including new teacher-created items designed to help students build skills through exploration, problem-solving, and active play. 

West and Brown are part of hand2mind’s growing network of teacher-author partners, bringing classroom expertise and educator-developed approaches to hands-on learning products for young learners. West is the creator of Little Minds at Work®, and her early literacy curriculum, Guided Phonics + Beyond®, is included on three state-approved lists. Brown is the creator of Teach Outside the Box® and STEM Bins® and is known for helping teachers make STEM exploration accessible, flexible, and engaging in everyday classroom settings. 

“Teachers are looking for low-prep classroom tools that are easy to implement, developmentally appropriate and rooted in how children actually learn,” said Elana Woldenberg Ruffman, CMO at hand2mind. “By working with teacher-authors like Tara West and Brooke Brown, hand2mind is bringing classroom-tested ideas to Target shelves in a way that supports educators during the back-to-school season and beyond.” 

The Target-exclusive products include: 

STEM Bins® by Brooke Brown Builder Pack ($24.99): Brown’s first product available at a major retailer; this set includes building materials and open-ended task cards that encourage students to design, create and problem-solve. It is designed for early finishers, centers, morning work, and makerspace time. Little Minds at Work® Early Math Activity Set ($21.99): Featuring West’s Pip the Pup character, this hands-on set helps students practice foundational math skills through matching, sorting, patterning, framing and comparing activities. The set includes 54 Pip the Pup counters and 20 double-sided activity cards. Little Minds at Work® Game Tray Activity Set ($19.99): This single-student activity set includes six double-sided math and literacy game boards and accessories for up to four players. The tray fits 8.5-by-11-inch paper, allowing teachers to swap in worksheets, game boards or custom activities. Little Minds at Work® Alphabet and Letter Sounds ($19.99): This hands-on activity set helps young learners practice CVC words, 26 core letter sounds, and early spelling skills. With colorful, reusable materials and engaging activities, children can identify beginning, middle, and ending sounds while strengthening fine motor skills through play. 

In addition to the Target-exclusive products, hand2mind’s back-to-school product lineup at Target includes a range of educational tools that support literacy, math, social-emotional learning, sensory play and hands-on skill-building. 

The hand2mind back-to-school product lineup is available at Target stores and Target.com. 

About hand2mind®   

At hand2mind®, we believe children learn best by doing. That’s why, for over 60 years, we’ve been creating hands-on learning tools and educational toys that help kids build skills through exploration, problem-solving, and active play. From math and STEM to literacy and social-emotional learning, our screen-free educational tool and toys support engaged skill development in grades PreK and up. We inspire curiosity, build confidence and make learning fun—at home, in the classroom, and beyond. Unlock the power of hands-on learning by visiting www.hand2mind.com or following the brand on TikTok @hand2mind, Facebook @hand2mindinc, and Instagram @hand2mindinc. 

MEDIA CONTACT  
Olivia Flores  
2139888344
416893@email4pr.com 

View original content to download multimedia:https://www.prnewswire.com/news-releases/hand2mind-launches-new-and-exclusive-back-to-school-products-at-target-302801508.html

SOURCE hand2mind

Continue Reading

Technology

Quick Fix Max™ ️Is Here, And It’s Everything Users Have Been Asking For

Published

on

By

LAS VEGAS, June 16, 2026 /PRNewswire/ — Quick Fix Synthetic, an authorized distributor of Quick Fix products, today announced the availability of Quick Fix Max 4 oz, a newly released addition to the Quick Fix product line from Spectrum Labs. Designed to offer increased volume and a ready-to-use standalone bottle format, Quick Fix Max uses the same Quick Fix 6.4 formula trusted for more than 25 years.

Quick Fix Max is a prefilled, premixed 4-ounce synthetic urine solution formulated to simulate key urine characteristics, including pH balance, specific gravity, creatinine levels, urea, and uric acid.

The product includes a temperature strip, heating pad, and batch verification code to support product authenticity and consistency. It introduces a larger standalone format for customers who prefer a simple bottle configuration while continuing to use the current Quick Fix 6.4 formula.

“Customers have consistently looked for a larger standalone Quick Fix option,” said by Chris Kennedy from Quick Fix Synthetic. “Quick Fix Max expands the existing lineup with the same trusted 6.4 formula in a format that offers more volume and better overall value.”

Quick Fix Max is a larger-volume format designed to offer improved per-ounce value while maintaining the same formula specifications and batch verification process customers already rely on.

Each Quick Fix Max package includes:

4 fl oz of Quick Fix 6.4 synthetic urineTemperature strip attached directly to the bottleHeat pad designed to maintain temperature for several hoursPrinted batch code for authenticity verificationTwo-year shelf life when stored correctly

Quick Fix Max has been officially released by Spectrum Labs and is now available through quickfixsynthetic.com and authorized distributors carrying official Quick Fix products.

Quick Fix Synthetic emphasized that purchasing through authorized distributors helps ensure customers receive authentic products stored under proper conditions, reducing the risk of expired or counterfeit units commonly associated with unverified third-party sellers and online marketplaces.

The company also noted that every Quick Fix Max bottle includes a printed batch number that can be verified through the official Quick Fix batch validator to confirm authenticity and expiration status before use.

Quick Fix Max is intended for novelty, calibration, educational, and laboratory simulation purposes only. Customers are encouraged to review all applicable local and state laws before purchase or use.

About Quick Fix Synthetic
Quick Fix Synthetic is an authorized distributor of Quick Fix products, providing customers with verified formula versions, batch authentication support, and direct customer service. The company focuses on educational resources, product authenticity, and discreet customer support while offering access to the latest Quick Fix formulations and related simulation products.

For more information, visit https://www.quickfixsynthetic.com.

Contact
Chris Kennedy
Manager
416750@email4pr.com
1-866-420-4574

View original content:https://www.prnewswire.com/news-releases/quick-fix-max-is-here-and-its-everything-users-have-been-asking-for-302801649.html

SOURCE Quick Fix Synthetic

Continue Reading

Technology

Aspirion Achieves HITRUST r2 Certification, Reinforcing Trust and Security Across Its AI-Powered Revenue Cycle Platforms

Published

on

By

HITRUST Certification validates that Aspirion’s Compass and DocIQ AI platforms meet rigorous cybersecurity and data protection standards through independent assessment and assurance.

COLUMBUS, Ga., June 16, 2026 /PRNewswire/ — Aspirion, the healthcare technology revenue cycle management (“RCM”) leader for denials, payment variance, and complex claims, today announced its Compass and DocIQ platforms have earned certified status from HITRUST for cybersecurity and information protection.

The HITRUST 2-year (r2) Certification demonstrates that Aspirion has met requirements defined by a leading cybersecurity assurance leader, confirming that strong controls are in place to protect sensitive data and manage risk effectively. As healthcare organizations increasingly adopt AI-enabled workflows, security, transparency, and governance become essential to scaling innovation responsibly.

“Our clients trust us with some of the most sensitive information in healthcare, and that trust is foundational to everything we do,” said Nick Giannasi, CEO of Aspirion. “Earning HITRUST r2 Certification for our Compass and DocIQ platforms reflects the significant investment we’ve made in building secure, trustworthy systems for healthcare providers. The sensitivity of the data we handle demands rigorous, continuously evolving controls, and this certification provides independent validation that those protections are in place.”

Built on the HITRUST Assurance Program, this achievement reflects independent third-party testing, centralized quality assurance, and certification backed by HITRUST’s Cyber Threat-Adaptive engine. These elements ensure continuous alignment with the latest threat intelligence and evolving standards across NIST, ISO, and OWASP.

“The HITRUST Assurance Program is rigorous and reliable because of the comprehensiveness of control requirements, depth of review, and consistency of oversight,” said Bimal Sheth, EVP, Standards Development & Assurance Operations at HITRUST. “HITRUST Certification demonstrates Aspirion is taking the most proactive approach to cybersecurity, data protection, and risk management.”

To learn more about HITRUST 2-year (r2) Certification, visit the HITRUST website at www.hitrustalliance.net. For more information about Aspirion, visit www.aspirion.com.

About Aspirion

Aspirion helps hospitals and health systems nationwide recover earned revenue from their most complex and difficult-to-resolve claims. Deploying proprietary AI and a specialized team of attorneys, clinicians, and claims experts, Aspirion overturns denials, recovers underpayments, and maximizes out-of-network and complex claim reimbursement—getting providers paid accurately, quickly, and transparently so they can focus on delivering affordable, accessible care. To learn more, visit www.aspirion.com.

Media Contact

Erin Haynie
Vice President, Marketing
Aspirion
erin.haynie@aspirion.com

View original content to download multimedia:https://www.prnewswire.com/news-releases/aspirion-achieves-hitrust-r2-certification-reinforcing-trust-and-security-across-its-ai-powered-revenue-cycle-platforms-302800805.html

SOURCE Aspirion

Continue Reading

Trending